Psychology Wiki

Assessment | Biopsychology | Comparative | Cognitive | Developmental | Language | Individual differences | Personality | Philosophy | Social |
Methods | Statistics | Clinical | Educational | Industrial | Professional items | World psychology |

Biological: Behavioural genetics · Evolutionary psychology · Neuroanatomy · Neurochemistry · Neuroendocrinology · Neuroscience · Psychoneuroimmunology · Physiological Psychology · Psychopharmacology (Index, Outline)

This article needs rewriting to enhance its relevance to psychologists..
Please help to improve this page yourself if you can..

Uric acid
Uric acid
Systematic name ?
Other names ?
Molecular formula ?
Molar mass ?.?? g/mol
Appearance ?
CAS number [?-?-?]
Density and phase ? g/cm³, ?
Solubility in water ? g/100 ml (?°C)
Melting point ?°C (? K)
Boiling point ?°C (? K)
Acidity (pKa) ?
Basicity (pKb) ?
Chiral rotation [α]D
Viscosity ? cP at ?°C
Molecular shape ?
Crystal structure ?
Dipole moment ? D
MSDS External MSDS
Main hazards ?
NFPA 704
Flash point ?°C
R/S statement R: ?
S: ?
RTECS number ?
Supplementary data page
Structure and
n, εr, etc.
Phase behaviour
Solid, liquid, gas
Spectral data UV, IR, NMR, MS
Related compounds
Other anions ?
Other cations ?
Related ? ?
Related compounds ?
Except where noted otherwise, data are given for
materials in their standard state (at 25 °C, 100 kPa)
Infobox disclaimer and references

Uric acid (or urate) is an organic compound of carbon, nitrogen, oxygen and hydrogen with the formula C5H4N4O3.


Uric acid is produced by xanthine oxidase from xanthine and hypoxanthine, which in turn are produced from purine. Uric acid is more toxic to tissues than either xanthine or hypoxanthine.

In humans and higher primates, uric acid is the final oxidation (breakdown) product of purine metabolism and is excreted in urine. In most other mammals, the enzyme uricase further oxidizes uric acid to allantoin.[1] The loss of uricase in higher primates parallels the similar loss of the ability to synthesize ascorbic acid.[2] Both uric acid and ascorbic acid are strong reducing agents (electron donors) and potent antioxidants. In humans, over half the antioxidant capacity of blood plasma comes from uric acid.

The Dalmatian dog has a genetic defect in uric acid uptake by the liver, resulting in decreased conversion to allantoin, so this breed excretes uric acid, and not allantoin, in the urine.[3]

In birds and reptiles, and in some desert dwelling mammals (eg kangaroo rat), uric acid also is the end product of purine metabolism, but it is excreted in feces as a dry mass. This involves a complex metabolic pathway that is energetically costly in comparison to processing of other nitrogenous wastes such as urea or ammonia, but has the advantage of reducing water loss.

In humans, about 70% of daily uric acid disposal occurs via the kidneys, and in 5-25% of humans impaired renal (kidney) excretion leads to hyperuricemia.[4]


A proportion of people have mutations in the proteins responsible for the excretion of uric acid by the kidneys. Four genes have so far been identified: SLC22A12, SLC2A9, ABCG2 and SLC17A3).[5] SLC2A9 is known to transport both uric acid and fructose.[4]


In human blood plasma, the reference range of uric acid is between 3.6 mg/dL (~214µmol/L) and 8.3 mg/dL (~494µmol/L) (1mg/dL=59.48 µmol/L).[6] This range is considered normal by the American Medical Association. Uric acid concentrations in blood plasma above and below the normal range are known, respectively, as hyperuricemia and hypouricemia. Similarly, uric acid concentrations in urine above and below normal are known as hyperuricosuria and hypouricosuria. Such abnormal concentrations of uric acid are not medical conditions, but are associated with a variety of medical conditions.

File:Reference ranges for blood tests - by mass.png

Reference ranges for blood tests, comparing blood content of uric acid (shown in green) with other constituents.

File:Reference ranges for blood tests - by molarity.png

Shown in molarity rather than mass. Uric acid shown in yellow.

High uric acid


Excess serum accumulation of uric acid can lead to a type of arthritis known as gout.[7]

Elevated serum uric acid (hyperuricemia) can result from high intake of purine-rich foods, high fructose intake (regardless of fructose's low glycemic index (GI) value) and/or impaired excretion by the kidneys. Saturation levels of uric acid in blood may result in one form of kidney stones when the urate crystallizes in the kidney. These uric acid stones are radiolucent and so do not appear on an abdominal plain x-ray or CT scan. Their presence must be diagnosed by ultrasound for this reason. Very large stones may be detected on x-ray by their displacement of the surrounding kidney tissues. Some patients with gout eventually get uric kidney stones.

Gout can occur where serum uric acid levels are as low as 6 mg/dL (~357µmol/L), but an individual can have serum values as high as 9.5 mg/dL (~565µmol/L) and not have gout[8] (no abstract available; levels reported at [9]).

Lesch-Nyhan syndrome

Lesch-Nyhan syndrome, an extremely rare inherited disorder, is also associated with very high serum uric acid levels.[10]

Spasticity, involuntary movement and cognitive retardation as well as manifestations of gout are seen in cases of this syndrome.[11]

Cardiovascular disease

Although uric acid can act as an antioxidant, excess serum accumulation is often associated with cardiovascular disease. It is not known whether this is causative (e.g., by acting as a prooxidant ) or a protective reaction taking advantage of urate's antioxidant properties.



The association of high serum uric acid with insulin resistance has been known since the early part of the 20th century, nevertheless, recognition of high serum uric acid as a risk factor for diabetes has been a matter of debate. In fact, hyperuricemia has always been presumed to be a consequence of insulin resistance rather than its precursor [13]. However, it was shown in a prospective follow-up study that high serum uric acid is associated with higher risk of type 2 diabetes independent of obesity, dyslipidemia, and hypertension [14].

Metabolic syndrome

Hyperuricemia is associated with components of metabolic syndrome and it has been debated for a while to be a component of it. It has been shown in a recent study that fructose-induced hyperuricemia may play a pathogenic role in the metabolic syndrome. This agrees with the increased consumption of fructose-base drinks in recent decades and the epidemic of diabetes and obesity [15].

Uric acid stone formation

Uric acid stones, which form in the absence of secondary causes such as chronic diarrhea, vigorous exercise, dehydration, and animal protein loading, are felt to be secondary to obesity and insulin resistance seen in metabolic syndrome. Increased dietary acid leads to increased endogenous acid production in the liver and muscles which in turn leads to an increased acid load to the kidneys. This load is handled more poorly because of renal fat infiltration and insulin resistance which are felt to impair ammonia excretion (a buffer). The urine is therefore quite acidic and uric acid becomes insoluble, crystallizes and stones form. In addition, naturally present promotor and inhibitor factors may be affected. This explains the high prevalence of uric stones and unusually acid urine seen in patients with type 2 diabetes. Uric acid crystals can also promote the formation of calcium oxalate stones, acting as "seed crystals" (heterogenous nucleation).[16]

Low uric acid

Multiple sclerosis

Lower serum values of uric acid have been associated with Multiple Sclerosis. Multiple sclerosis (MS) patients have been found to have serum levels ~194µmol/L, with patients in relapse averaging ~160µmol/L and patients in remission averaging ~230µmol/L. Serum uric acid in healthy controls was ~290µmol/L.[17] Conversion factor: 1mg/dL=59.48 µmol/L[6]

A 1998 study completed a statistical analysis of 20 million patient records, comparing serum uric acid values in patients with gout and patients with multiple sclerosis. Almost no overlap between the groups was found.[18]

Uric acid has been successfully used in the treatment and prevention of the animal (murine) model of MS. A 2006 study found that elevation of serum uric acid values in multiple sclerosis patients, by oral supplementation with inosine, resulted in lower relapse rates, and no adverse effects.[19]

Oxidative stress

Uric acid may be a marker of oxidative stress,[20] and may have a potential therapeutic role as an antioxidant.[21] On the other hand, like other strong reducing substances such as ascorbate, uric acid can also act as a prooxidant,[22] particularly at elevated levels. Thus, it is unclear whether elevated levels of uric acid in diseases associated with oxidative stress such as stroke and atherosclerosis are a protective response or a primary cause.[23]

For example, some researchers propose that hyperuricemia-induced oxidative stress is a cause of metabolic syndrome.[24][25] On the other hand, plasma uric acid levels correlate with longevity in primates and other mammals.[26] This is presumably a function of urate's antioxidant properties.

Sources of uric acid

  • In many instances, people have elevated uric acid levels for hereditary reasons. Diet may also be a factor.
  • Purines are found in high amounts in animal internal organ food products, such as liver.[27] A moderate amount of purine is also contained in beef, pork, poultry, fish and seafood, asparagus, cauliflower, spinach, mushrooms, green peas, lentils, dried peas, beans, oatmeal, wheat bran and wheat germ.[28]
  • Examples of high purine sources include: sweetbreads, anchovies, sardines, liver, beef kidneys, brains, meat extracts (e.g Oxo, Bovril), herring, mackerel, scallops, game meats, and gravy.
  • Moderate intake of purine-containing food is not associated with an increased risk of gout.[29]
  • Serum uric acid can be elevated due to high fructose intake [24], reduced excretion by the kidneys, and or high intake of dietary purine.
  • Added fructose can be found in processed foods and soda beverages as sucrose, or in some countries, as high fructose corn syrup.

Causes of low uric acid

Low uric acid (hypouricemia) can have numerous causes.

Sevelamer, a drug indicated for prevention of hyperphosphataemia in patients with chronic renal failure, can significantly reduce serum uric acid.[30]

Other uric acid facts

The crystalline form of uric acid is used as a reflector in certain species of fireflies.

The uric acid in urine can also dry in a baby's diaper to form a pinkish powder that is harmless.

See also

  • Hyperuricemia

References & Bibliography

  1. Purine and Pyrimidine Metabolism
  2. Proctor, P. (1970). Similar Functions of Uric Acid and Ascorbate in Man. Nature 228: 868.
  3. Friedamman, M; S.O Byers (1948). Observations concerning the causes of the excess excretion of uric acid in the dalmatian dog. Journal of Biological Chemistry 175(2): 727–35.
  4. 4.0 4.1 Vitart V, Rudan I, Hayward C, Gray NK, Floyd J, Palmer CN, Knott SA, Kolcic I, Polasek O, Graessler J, Wilson JF, Marinaki A, Riches PL, Shu X, Janicijevic B, Smolej-Narancic N, Gorgoni B, Morgan J, Campbell S, Biloglav Z, Barac-Lauc L, Pericic M, Klaric IM, Zgaga L, Skaric-Juric T, Wild SH, Richardson WA, Hohenstein P, Kimber CH, Tenesa A, Donnelly LA, Fairbanks LD, Aringer M, McKeigue PM, Ralston SH, Morris AD, Rudan P, Hastie ND, Campbell H, Wright AF (April 2008). SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout. Nat. Genet. 40 (4): 437–42.
  5. Aringer M, Graessler J (2008). Understanding deficient elimination of uric acid. Lancet 372 (9654): 1929–1930.
  6. 6.0 6.1 SI Units for Clinical Data
  7. Tausche AK et al. (2006). Hyperuricemia and gout: diagnosis and therapy. Article in German. Internist (Berl). 47(5): 509–20.
  8. Laster L, Howell RR. (1963). Biochemistry of uric acid and its relation to gout. N Engl J Med 268: 764–73.
  9. Uric Acid, Serum
  10. Luo YC et al. (2006). An amperometric uric acid biosensor based on modified Ir-C electrode. Biosens Bioelectron 22(4): 482–8.
  11. Nyhan WL (2005). Lesch-Nyhan Disease. J Hist Neurosci 14(1): 1–10.
  12. Heinig M, Johnson RJ. (2006). Role of uric acid in hypertension, renal disease, and metabolic syndrome. Cleve Clin J Med. 73(12): 1059–64.
  13. Cappuccio FP, et al (1993). Uric acid metabolism and tubular sodium handling. Results from a population-based study. Jama 270--- (3): 354–359.
  14. Dehghan A. et al (2007). High serum uric acid as a novel risk factor for type 2 diabetes mellitus. Diabetes Care 31: 361.
  15. Nakagawa T, Hu H, Zharikov S, et al. (2006). A causal role for uric acid in fructose-induced metabolic syndrome. Am J Physiol Renal Physiol. 290 (3): F625–631.
  16. Charles Y.C. Pak (2008). Metabolic Stone Management: 35 Years of Advances.. Journal of Urology 180 pages = 813-819.
  17. Toncev G, et al. (2002). Serum uric acid levels in multiple sclerosis patients correlate with activity of disease and blood-brain barrier dysfunction. Eur J Neurol. 9(3): 221–6.
  18. Hooper DC, et al. (1998). Uric acid, a natural scavenger of peroxynitrite, in experimental allergic encephalomyelitis and multiple sclerosis. Proc Natl Acad Sci U S A. 95(2): 675–80.
  19. Toncev G (2006). Therapeutic value of serum uric acid levels increasing in the treatment of multiple sclerosis. Vojnosanit Pregl. 63(10): 879–82.
  20. Becker BF (June 1993). Towards the physiological function of uric acid. Free radical biology & medicine 14 (6): 615–31.
  21. Glantzounis GK, Tsimoyiannis EC, Kappas AM, Galaris DA (2005). Uric acid and oxidative stress. Current pharmaceutical design 11 (32): 4145–51.
  22. Proctor P. (1972). Electron-transfer factors in psychosis and dyskinesia. Physiol Chem Phys. 4(4): 349–60.
  23. Free Radicals and Human Disease
  24. 24.0 24.1 Nakagawa T, et al (2006). A causal role for uric acid in fructose-induced metabolic syndrome. Am J Physiol Renal Physiol. 290(3): F625–31.
  25. Hayden MR, Tyagi SC. (2004). Uric acid: A new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: The urate redox shuttle. Nutr Metab. 1(1): 10.
  26. Cutler RG. (1984). Urate and ascorbate: their possible roles as antioxidants in determining longevity of mammalian species. Arch Gerontol Geriatr. 3(4): 321–48.
  27. Gout Causes: List of Diet/Food Sources High or Low in Purine Content
  28. Gout Diet / Low Purine Diet - Limit High Purine foods
  29. Choi HK, et al. (2004). Purine-rich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med. 350(11): 1093–103.
  30. Garg JP, Chasan-Taber S, Blair A, et al (January 2005). Effects of sevelamer and calcium-based phosphate binders on uric acid concentrations in patients undergoing hemodialysis: a randomized clinical trial. Arthritis and rheumatism 52 (1): 290–5.

Further reading

Key texts



  • Ahern, F. M., Johnson, R. C., & Ashton, G. C. (1980). Family resemblances in serum uric acid level: Behavior Genetics Vol 10(3) May 1980, 303-307.
  • Alonso, A., & Hernan, M. A. (2008). "Gout and risk of Parkinson disease: A prospective study": Reply: Neurology Vol 71(1) Jul 2008, 70.
  • Astakhova, L. N., & Asanova, N. K. (1987). Borderline neuropsychiatric disorders secondary to disorders in purine metabolism in children: Soviet Neurology & Psychiatry Vol 20(1) Spr 1987, 62-71.
  • Barrera, C. M., Hunter, R. E., & Dunlap, W. P. (1989). Hyperuricemia and locomotor activity in developing rats: Pharmacology, Biochemistry and Behavior Vol 33(2) Jun 1989, 367-369.
  • Barrera, C. M., Ruiz, Z. R., & Dunlap, W. P. (1988). Uric acid: A participating factor in the symptoms of hyperactivity: Biological Psychiatry Vol 24(3) Jul 1988, 344-347.
  • Bavaresco, C. S., Zugno, A. I., Tagliari, B., Wannmacher, C. M. D., Wajner, M., & Wyse, A. T. S. (2004). Inhibition of Na-super(+), K-super(+)-ATPase activity in rat striatum by the metabolites accumulated in Lesch-Nyhan disease: International Journal of Developmental Neuroscience Vol 22(1) Feb 2004, 11-17.
  • Benel, R. A. (1976). Note on the relationship between n Ach and uric acid: Psychological Reports Vol 39(2) Oct 1976, 524-526.
  • Biersner, R. J., McHugh, W. B., & Rahe, R. H. (1981). Biochemical variability in a team sports situation: Journal of Human Stress Vol 7(3) Sep 1981, 12-17.
  • Biersner, R. J., McHugh, W. B., & Rahe, R. H. (1984). Biochemical and mood responses predictive of stressful diving performance: Journal of Human Stress Vol 10(1) Spr 1984, 43-49.
  • Bloch, M., Gur, E., & Shalev, A. Y. (1992). Hypouricemic effect of zuclopenthixol: A potential marker of drug compliance? : Psychopharmacology Vol 109(3) Nov 1992, 377-378.
  • Bloch, S., & Brackenridge, C. J. (1972). Psychological, performance and biochemical factors in medical students under examination stress: Journal of Psychosomatic Research Vol 16(1) Feb 1972, 25-33.
  • Bowers, M. B., & Study, R. E. (1979). Cerebrospinal fluid cyclic AMP and acid monoamine metabolites following probenecid: Studies in psychiatric patients: Psychopharmacology Vol 62(1) 1979, 17-22.
  • Brooks, S. C., Linn, J. J., & Disney, N. (1978). Serotonin, folic acid, and uric acid metabolism in the diagnosis of neuropsychiatric disorders: Biological Psychiatry Vol 13(6) Dec 1978, 671-684.
  • Campbell, C. S., & Davis, J. D. (1974). Licking rate of rats is reduced by intraduodenal and intraportal glucose infusion: Physiology & Behavior Vol 12(3) Mar 1974, 357-365.
  • Chen, T.-T., Chen, J.-Y., Bai, Y.-M., & Lin, C.-C. (2006). The effects of zotepine in treating psychotic patients with hyperuricaemia: A case series: International Journal of Neuropsychopharmacology Vol 9(2) Apr 2006, 259-261.
  • Fatokun, A. A., Stone, T. W., & Smith, R. A. (2008). Prolonged exposures of cerebellar granule neurons to S-nitroso-N-acetylpenicillamine (SNAP) induce neuronal damage independently of peroxynitrite: Brain Research Vol 1230 Sep 2008, 265-272.
  • Flemenbaum, A., & Anderson, R. P. (1978). Field dependence and blood cholesterol: An expansion: Perceptual and Motor Skills Vol 46(3, Pt 1) Jun 1978, 867-874.
  • Flemenbaum, A., & Flemenbaum, E. (1975). Field dependence, blood uric acid and cholesterol: Perceptual and Motor Skills Vol 41(1) Aug 1975, 135-141.
  • Fowler, M. G. (1973). Relationship of serum uric acid to achievement motivation: Psychosomatic Medicine Vol 35(1) Jan 1973, 13-22.
  • Francis, K. T. (1979). Psychologic correlates of serum indicators of stress in man: A longitudinal study: Psychosomatic Medicine Vol 41(8) Dec 1979, 617-628.
  • Fuzikawa, A. K., Peixoto, S. V., Moriguchi, M. T. E. H., & Lima-Costa, M. F. (2008). "Association of ApoE polymorphisms with prevalent hypertension in 1406 older adults: the Bambui Health Aging Study (BHAS)": Correction: Brazilian Journal of Medical and Biological Research Vol 41(7) Jul 2008, 640-641.
  • Grunberg, N. E., Morse, D. E., & Barrett, J. E. (1983). Effects of urinary pH on the behavioral responses of squirrel monkeys to nicotine: Pharmacology, Biochemistry and Behavior Vol 19(3) Sep 1983, 553-557.
  • Guerrero, A. L., Martin-Polo, J., Laherran, E., Gutierrez, F., Iglesias, F., Tejero, M. A., et al. (2008). Variation of serum uric acid levels in multiple sclerosis during relapses and immunomodulatory treatment: European Journal of Neurology Vol 15(4) Apr 2008, 394-397.
  • Guevara-Lopez, U., Ayala-Guerrero, F., Covarrubias-Gomez, A., Lopez-Munoz, F. J., & Torres-Gonzalez, R. (2009). Effect of acute gouty arthritis on sleep patterns: A preclinical study: European Journal of Pain Vol 13(2) Feb 2009, 146-153.
  • Gupta, M. A., & Kavanaugh-Danelon, D. (1989). Elevated serum uric acid in eating disorders: A possible index of strenuous physical activity and starvation: International Journal of Eating Disorders Vol 8(4) Jul 1989, 463-471.
  • Hanihara, T., Amagai, I., Hagimoto, H., & Makimoto, Y. (1997). Hypouricemia in chronic schizophrenic patients with polydipsia and hyponatremia: Journal of Clinical Psychiatry Vol 58(6) Jun 1997, 256-260.
  • Howard, J. H., Cunningham, D. A., & Rechnitzer, P. A. (1976). Health patterns associated with Type A behavior: A managerial population: Journal of Human Stress Vol 2(1) Mar 1976, 24-31.
  • Inouye, E., Park, K. S., & Asaka, A. (1984). Blood uric acid level and IQ: A study in twin families: Acta Geneticae Medicae et Gemellologiae: Twin Research Vol 33(2) 1984, 237-242.
  • Iwasaki, Y., Kano, O., & Ikeda, K. (2008). Gout and risk of Parkinson disease: A prospective Study: Neurology Vol 71(1) Jul 2008, 70.
  • Kanabrocki, E. L., Ryan, M. D., Hermida, R. C., Ayala, D. E., Scott, G. S., Murray, D., et al. (2004). Altered circadian relationship between serum nitric oxide, carbon dioxide, and uric acid in multiple sclerosis: Chronobiology International Vol 21(4-5) 2004, 739-758.
  • Kasl, S. V. (1974). Are there any promising biochemical correlates of achievement behavior and motivation? The evidence for serum uric acid and serum cholesterol: Review of Educational Research Vol 44(4) Fal 1974, 447-462.
  • Katz, J. L., & Weiner, H. (1972). Psychosomatic considerations in hyperuricemia and gout: Psychosomatic Medicine Vol 34(2) Mar 1972, 165-182.
  • Katz, J. L., & Weiner, H. (1975). Psychosomatic considerations in uricemia and gout: Medicina Psicosomatica Vol 20(2) Apr-Jul 1975, 115-122.
  • Keast, R. S. J., & Breslin, P. A. S. (2002). Cross-adaptation and bitterness inhibition of {L}-tryptophan, {L}-phenylalanine and urea: Further support for shared peripheral physiology: Chemical Senses Vol 27(2) Feb 2002, 123-131.
  • Kendrick, K. M., Keverne, E. B., Chapman, C., & Baldwin, B. A. (1988). Intracranial dialysis measurement of oxytocin, monoamine and uric acid release from the olfactory bulb and substantia nigra of sheep during parturition, suckling, separation from lambs and eating: Brain Research Vol 439(1-2) Jan 1988, 1-10.
  • Kennett, K. F., & Cropley, A. J. (1975). Uric acid and divergent thinking: A possible relationship: British Journal of Psychology Vol 66(2) May 1975, 175-180.
  • Kim, T.-S., Pae, C.-U., Yoon, S.-J., Jang, W.-Y., Lee, N. J., Kim, J.-J., et al. (2006). Decreased plasma antioxidants in patients with Alzheimer's disease: International Journal of Geriatric Psychiatry Vol 21(4) Apr 2006, 344-348.
  • Kutzing, M. K., & Firestein, B. L. (2008). Altered uric acid levels and disease states: Journal of Pharmacology and Experimental Therapeutics Vol 324(1) Jan 2008, 1-7.
  • Launay, J. M., Ferrari, P., Haimart, M., Bursztejn, C., & et al. (1988). Serotonin metabolism and other biochemical parameters in infantile autism: A controlled study of 22 autistic children: Neuropsychobiology Vol 20(1) 1988, 1-11.
  • Layton, M. E., Samson, F. E., & Pazdernik, T. L. (1998). Kainic acid causes redox changes in cerebral cortex extracellular fluid: NMDA receptor activity increases ascorbic acid whereas seizure activity increases uric acid: Neuropharmacology Vol 37(2) Feb 1998, 149-157.
  • Machado-Viera, R., Lara, D. R., Souza, D. O., & Kapczinski, F. (2001). Therapeutic efficacy of allopurinol in mania associated with hyperuricemia: Journal of Clinical Psychopharmacology Vol 21(6) Dec 2001, 621-622.
  • Maesaka, J. K., Wolf-Klein, G., Piccione, J. M., & Ma, C. M. (1993). Hypouricemia, abnormal renal tubular urate transport, and plasma natriuretic factor(s) in patients with Alzheimer's disease: Journal of the American Geriatrics Society Vol 41(5) May 1993, 501-506.
  • Maillot, F., & Crenn, P. (2007). Urea cycle disorders in adult patients: Revue Neurologique Vol 163(10) Oct 2007, 897-903.
  • Manowitz, P., Amorosa, L. F., Goldstein, H. S., & Carlton, P. L. (1993). Uric acid level increases in humans engaged in gambling: A preliminary report: Biological Psychology Vol 36(3) Sep 1993, 223-229.
  • Mueller, E. F., & French, J. R. (1974). Uric acid and achievement: Journal of Personality and Social Psychology Vol 30(3) Sep 1974, 336-340.
  • Nance, D. M., & Gorski, R. A. (1973). Effects of chronic diabetes on 2-deoxy-D-glucose induced feeding and drinking: Pharmacology, Biochemistry and Behavior Vol 1(4) Jul 1973, 483-485.
  • Nanji, A. A., & French, S. W. (1986). Correlations between deviations from expected cirrhosis mortality and serum uric acid and dietary protein intake: Journal of Studies on Alcohol Vol 47(3) May 1986, 253-255.
  • Niklasson, F., & Agren, H. (1984). Brain energy metabolism and blood-brain barrier permeability in depressive patients: Analyses of creatine, creatinine, urate, and albumin in CSF and blood: Biological Psychiatry Vol 19(8) Aug 1984, 1183-1206.
  • Nomikos, G. G., Zis, A. P., Damsma, G., & Fibiger, H. C. (1991). Electroconvulsive shock produces large increases in interstitial concentrations of dopamine in the rat striatum: An in vivo microdialysis study: Neuropsychopharmacology Vol 4(1) Jan 1991, 65-69.
  • Okada, K., & Fujii, I. (1990). Serum uric acid and mania: Kyushu Neuro-psychiatry Vol 36(2) Aug 1990, 122-126.
  • O'Neill, R. D., & Lowry, J. P. (1995). On the significance of brain extracellular uric acid detected with in-vivo monitoring techniques: A review: Behavioural Brain Research Vol 71(1-2) Nov 1995, 33-49.
  • Ooki, S., Yamada, K., & Asaka, A. (1990). Relationship between blood uric acid level and personality traits: Acta Geneticae Medicae et Gemellologiae: Twin Research Vol 39(1) 1990, 117-122.
  • Osborne, P. G., & Hashimoto, M. (2007). Brain ECF antioxidant interactions in hamsters during arousal from hibernation: Behavioural Brain Research Vol 178(1) Mar 2007, 115-122.
  • Peeters, M. A., Megarbane, A., Cattaneo, F., & Rethore, M. O. (1993). Differences in purine metabolism in patients with Down's syndrome: Journal of Intellectual Disability Research Vol 37(6) Dec 1993, 491-505.
  • Rahe, R. H., Rubin, R. T., & Arthur, R. J. (1974). The three investigators study: Serum uric acid, cholesterol, and cortisol variability during stresses of everyday life: Psychosomatic Medicine Vol 36(3) May 1974, 258-268.
  • Raina, M. K., & Vats, A. (1980). Birth order and uric acid concentrations: Biological Psychology Vol 11(3-4) Nov-Dec 1980, 257-259.
  • Raina, M. K., & Vats, A. (1982). Serum uric acid, serum cholesterol and intelligence: Journal of Psychological Researches Vol 26(1) Jan 1982, 28-34.
  • Raina, M. K., & Vats, A. (1982). Serum uric acid, serum cholesterol and personality: Journal of Psychosomatic Research Vol 26(3) 1982, 291-299.
  • Reddy, R., Keshavan, M., & Yao, J. K. (2003). Reduced plasma antioxidants in first-episode patients with schizophrenia: Schizophrenia Research Vol 62(3) Aug 2003, 205-212.
  • Reichelt, K.-L. (1983). Peptide containing fractions from schizophrenic urines: Tidsskrift for Norsk Psykologforening Vol 20(8) Aug 1983, 420-428.
  • Ruggiero, C., Cherubini, A., Guralnik, J., Semba, R. D., Maggio, M., Ling, S. M., et al. (2007). The interplay between uric acid and antioxidants in relation to physical function in older persons: Journal of the American Geriatrics Society Vol 55(8) Aug 2007, 1206-1215.
  • Sato, T., & Sata, O. (1989). Taste thresholds of Japanese dental students to phenylthiocarbamide: Chemical Senses Vol 14(6) Dec 1989, 847-851.
  • Schal, C., & Bell, W. J. (1982). Ecological correlates of paternal investment of urates in a tropical cockroach: Science Vol 218(4568) Oct 1982, 170-173.
  • Schiess, M., & Oh, I. (2008). Serum uric acid and clinical progression in Parkinson disease: Potential biomarker for nigrostriatal failure: Archives of Neurology Vol 65(6) Jun 2008, 698-699.
  • Schretlen, D. J., Inscore, A. B., Jinnah, H. A., Rao, V., Gordon, B., & Pearlson, G. D. (2007). Serum uric acid and cognitive function in community-dwelling older adults: Neuropsychology Vol 21(1) Jan 2007, 136-140.
  • Schretlen, D. J., Inscore, A. B., Vannorsdall, T. D., Kraut, M., Pearlson, G. D., Gordon, B., et al. (2007). Serum uric acid and brain ischemia in normal elderly adults: Neurology Vol 69(14) Oct 2007, 1418-1423.
  • Schwarzschild, M. A., Schwid, S. R., Marek, K., Watts, A., Lang, A. E., Oakes, D., et al. (2008). Serum urate as a predictor of clinical and radiographic progression in Parkinson disease: Archives of Neurology Vol 65(6) Jun 2008, 714-723.
  • Shin, H.-S., Lee, H.-R., Lee, D.-C., Shim, J.-Y., Cho, K.-H., & Suh, S.-Y. (2006). Uric Acid as a Prognostic Factor for Survival Time: A Prospective Cohort Study of Terminally Ill Cancer Patients: Journal of Pain and Symptom Management Vol 31(6) Jun 2006, 493-501.
  • Shirom, A., Melamed, S., & Nir-Dotan, M. (2000). The relationships among objective and subjective environmental stress levels and serum uric acid: The moderating effect of perceived control: Journal of Occupational Health Psychology Vol 5(3) Jul 2000, 374-385.
  • Spitz, R. T., Hillbrand, M., & Foster, H. G. (1995). Uric acid levels and severity of aggression: Psychological Reports Vol 76(1) Feb 1995, 130.
  • Stevens, H. A. (1973). A multi-disciplinary catalogue of uric acid literature of interest to behavioural scientists: Perceptual and Motor Skills Vol 36(3, Pt 1) Jun 1973, 1007-1020.
  • Stevens, H. A., & Cropley, A. J. (1972). Uric acid and behaviour: A new look at Orowan's hypothesis: Psychological Reports Vol 30(3) Jun 1972, 967-970.
  • Sumi, T., & Umeda, Y. (1977). Hyperuricemia in the rat following hypothalamic stimulation: Life Sciences Vol 21(11) Dec 1977, 1675-1678.
  • Thomas, P. D., Goodwin, J. M., & Goodwin, J. S. (1985). Effect of social support on stress-related changes in cholesterol level, uric acid level, and immune function in an elderly sample: American Journal of Psychiatry Vol 142(6) Jun 1985, 735-737.
  • Tochigi, M., Umekage, T., Otani, T., Kato, T., Iwanami, A., Asukai, N., et al. (2002). Serum cholesterol, uric acid and cholinesterase in victims of the Tokyo subway sarin poisoning: A relation with post-traumatic stress disorder: Neuroscience Research Vol 44(3) Nov 2002, 267-272.
  • Trevisan, M., O'Leary, E., Farinaro, E., Jossa, F., Galasso, R., Celentano, E., et al. (1997). Short- and long-term association between uric acid and a natural disaster: Psychosomatic Medicine Vol 59(2) Mar-Apr 1997, 109-113.
  • Verhoeven, A., Musch, W., & Decaux, G. (2005). Treatment of the Polydipsia-Hyponatremia Syndrome With Urea: Journal of Clinical Psychiatry Vol 66(11) Nov 2005, 1372-1375.
  • Wright, J. T., & Das, A. K. (1973). Urinary excretion of homovanillic acid (HVA) and vanillylmandelic acid (VMA) in patients with diarrhoea of presumed nervous origin: Journal of Psychosomatic Research Vol 17(2) Mar 1973, 155-157.

Additional material


  • Butcher, R. E., Hawver, K., Burbacher, T., & Scott, W. (1975). Behavioral effects from antenatal exposure to teratogens. Oxford, England: Lawrence Erlbaum.



  • Aagaard, N. K., Thogersen, T., Grofte, T., Greisen, J., & Vilstrup, H. (2004). Alcohol Acutely Down-Regulates Urea Synthesis in Normal Men: Alcoholism: Clinical and Experimental Research Vol 28(5) May 2004, 697-701.
  • Hunter, R. E. (1988). Uric acid and adenosine binding in young rats: A potential model of hyperactivity: Dissertation Abstracts International.
  • Keehner, J. M. (1979). The relationship of serum uric acid to intelligence, achievement, and need for achievement in U.S. adolescents, twelve through seventeen years of age, 1966-1970: Dissertation Abstracts International.
  • Kennett, K. F. (1973). Serum uric acid, intellect, and personality: Dissertation Abstracts International.
  • Manning, M. R. (1980). Effects of role conflict on registered nurses' physiological, affective, and performance responses: A labortory simulation: Dissertation Abstracts International.
  • Sayetta, R. B. (1986). The relationship of anxiety and serum uric acid: A model of psychosomatic disease: Dissertation Abstracts International.
  • Stevens, H. A. (1974). Serum uric acid: A biochemical factor in learning: Dissertation Abstracts International.

External links


Template:Nucleotide metabolism intermediates